Skip to content

Retrospective, randomized and self-controlled clinical study of laparoscopic modified radical inguinal lymph node dissection for penile carcinoma

Retrospective, randomized and self-controlled clinical study of laparoscopic modified radical inguinal lymph node dissection for penile carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023549
Enrollment
Unknown
Registered
2019-06-01
Start date
2019-05-31
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

penile cancer

Interventions

56 patients at left side versus 56 patients at right side:laparoscopic surgery versus open surgery in modified radical inguinal lymph node dissection

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Routine physical examination and imaging evaluation of patients with penile cancer without distant metastasis (cN0-2); Preoperative primary focal point and Sentinel lymph node biopsy were identified with pathological staging and classification. Penile squamous cell carcinoma; Patients with pTxN0-2M0; 2. Aged 18-80, life expectancy greater than 2 years, Karnofsky score = 60 points(see schedule 2); 3. Blood routine: WBC = 3.5 × 10^9/L, the absolute value of centrocytes = 2.0 × 10^9/L, PLT = 100.0 × 10^9/L, HGb = 90g/L; Liver function: bilirubin, gamma-GT, ALP and LDH are all below the upper limit of normal values; SGOT and SGPT are 2.5 times lower than the upper limit of normal values; Kidney function: Creatinine is 1.25 times lower than the upper limit of the normal value; Heart function 0-2; 4. Voluntary participation in the study and signature of informed consent. (* Total number of single lymph nodes cleared requires at least 8 or more).

Exclusion criteria

Exclusion criteria: 1. Non-squamous cell carcinoma, such as adenocarcinoma, malignant melanoma, etc.; 2. Preoperative primary focal and desorption with lymph node biopsy confirmed pN3M1 patients 3. Can touch unilateral or bilateral inactive lymph nodes or pelvic lymph node metastasis(cN3 phase); Skin ulceration; 4. Preoperative pathological stage and classification are not clear, lymph node biopsy pathology is unknown; The pathological examination of lymph nodes did not meet the prescribed requirements(unilateral clearance and pathological examination of lymph nodes less than 8, pathology can not define N0), can not accurately determine the postoperative pathological N stage; 5. Neoadjuvant chemotherapy was performed within 3 months before operation. In the 6 months before surgery, the original focal or ventral zone radiotherapy = 30Gy; 6. Severe liver and kidney dysfunction; Merge other serious diseases; Cardiac insufficiency, or angina, arrhythmias, and uncontrolled hypertension, with a history of myocardial infarction within one year.

Design outcomes

Primary

MeasureTime frame
Disease Free Survival;Disease free survival time;

Countries

China

Contacts

Public ContactZhang Xueqi

Shenzhen People's Hospital

573589539@qq.com+86 15915720056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026